Risk factors for intracerebral hemorrhage in patients with COVID-19

Kara R Melmed1,2, Meng Cao3, Siddhant Dogra4

  • 1Department of Neurology, New York University Langone Health, New York, NY, USA. kara.melmed@nyulangone.org.

Insights

Therapeutic anticoagulation significantly increases the risk of intracerebral hemorrhage (ICH) in patients with coronavirus disease (COVID-19). This finding highlights the need for careful consideration of anticoagulation strategies in COVID-19 patients to mitigate ICH risk.

Area of Science:

  • Neurology
  • Infectious Diseases
  • Critical Care Medicine

Background:

  • Intracerebral hemorrhage (ICH) is a severe complication of coronavirus disease (COVID-19).
  • Identifying risk factors for ICH in COVID-19 patients is crucial for management.
  • Previous studies have not fully elucidated the specific risks associated with COVID-19 and ICH.

Purpose of the Study:

  • To assess risk factors associated with intracerebral hemorrhage (ICH) in patients with COVID-19.
  • To determine the association between anticoagulation therapy and ICH in this patient population.
  • To evaluate the impact of ICH on mortality in COVID-19 patients.

Main Methods:

  • Retrospective cohort study of adult COVID-19 patients admitted between March 1 and April 27, 2020.
  • Inclusion criteria: positive COVID-19 test, primary non-traumatic intracranial hemorrhage or hemorrhagic conversion of ischemic stroke on neuroimaging.
  • Exclusion criteria: intracranial procedures, malignancy, vascular malformation. Regression models used to analyze risk factors and mortality.

Main Results:

  • Out of 416 eligible COVID-19 patients, 33 (7.9%) experienced ICH.
  • Univariate analysis showed older age, non-Caucasian race, respiratory failure requiring mechanical ventilation, and therapeutic anticoagulation were associated with ICH.
  • Adjusted regression models revealed anticoagulation use increased ICH risk five-fold (OR 5.26, p < 0.001).
  • ICH was associated with increased mortality (adjusted OR 2.6, p < 0.05).

Conclusions:

  • Therapeutic anticoagulation is a significant risk factor for intracerebral hemorrhage in COVID-19 patients.
  • Intracerebral hemorrhage is linked to increased mortality in the COVID-19 population.
  • Further research is needed to understand mechanisms and develop prevention strategies for ICH in COVID-19.

Related Concept Videos

Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
13.1K
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
235
Factors affecting Blood pressure01:28

Factors affecting Blood pressure

Several physiological and lifestyle factors influence blood pressure (BP). Understanding these factors is crucial as they are significant in patient education and blood pressure management.
Physiological Factors:
6.0K
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.7K